BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15661739)

  • 1. Repression and coactivation of CCAAT/enhancer-binding protein epsilon by sumoylation and protein inhibitor of activated STATx proteins.
    Kim J; Sharma S; Li Y; Cobos E; Palvimo JJ; Williams SC
    J Biol Chem; 2005 Apr; 280(13):12246-54. PubMed ID: 15661739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PIAS1 and PIASxalpha function as SUMO-E3 ligases toward androgen receptor and repress androgen receptor-dependent transcription.
    Nishida T; Yasuda H
    J Biol Chem; 2002 Nov; 277(44):41311-7. PubMed ID: 12177000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A synergy control motif within the attenuator domain of CCAAT/enhancer-binding protein alpha inhibits transcriptional synergy through its PIASy-enhanced modification by SUMO-1 or SUMO-3.
    Subramanian L; Benson MD; Iñiguez-Lluhí JA
    J Biol Chem; 2003 Mar; 278(11):9134-41. PubMed ID: 12511558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases.
    Kotaja N; Karvonen U; Jänne OA; Palvimo JJ
    Mol Cell Biol; 2002 Jul; 22(14):5222-34. PubMed ID: 12077349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional activity of CCAAT/enhancer-binding proteins is controlled by a conserved inhibitory domain that is a target for sumoylation.
    Kim J; Cantwell CA; Johnson PF; Pfarr CM; Williams SC
    J Biol Chem; 2002 Oct; 277(41):38037-44. PubMed ID: 12161447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FLI-1 functionally interacts with PIASxalpha, a member of the PIAS E3 SUMO ligase family.
    van den Akker E; Ano S; Shih HM; Wang LC; Pironin M; Palvimo JJ; Kotaja N; Kirsh O; Dejean A; Ghysdael J
    J Biol Chem; 2005 Nov; 280(45):38035-46. PubMed ID: 16148010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein partners of C/EBPepsilon.
    Chih DY; Park DJ; Gross M; Idos G; Vuong PT; Hirama T; Chumakov AM; Said J; Koeffler HP
    Exp Hematol; 2004 Dec; 32(12):1173-81. PubMed ID: 15588942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional activity of peroxisome proliferator-activated receptor gamma is modulated by SUMO-1 modification.
    Ohshima T; Koga H; Shimotohno K
    J Biol Chem; 2004 Jul; 279(28):29551-7. PubMed ID: 15123625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity.
    Schmidt D; Müller S
    Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2872-7. PubMed ID: 11867732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sumoylation of Rta of Epstein-Barr virus is preferentially enhanced by PIASxbeta.
    Liu ST; Wang WH; Hong YR; Chuang JY; Lu PJ; Chang LK
    Virus Res; 2006 Aug; 119(2):163-70. PubMed ID: 16460827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SUMO modification of STAT1 and its role in PIAS-mediated inhibition of gene activation.
    Rogers RS; Horvath CM; Matunis MJ
    J Biol Chem; 2003 Aug; 278(32):30091-7. PubMed ID: 12764129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role for SUMO modification in facilitating transcriptional repression by BKLF.
    Perdomo J; Verger A; Turner J; Crossley M
    Mol Cell Biol; 2005 Feb; 25(4):1549-59. PubMed ID: 15684403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCAAT/Enhancer-Binding Protein ε
    Stankiewicz MJ; Du J; Martinico D; Ackerman SJ
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yeast PIAS-type Ull1/Siz1 is composed of SUMO ligase and regulatory domains.
    Takahashi Y; Kikuchi Y
    J Biol Chem; 2005 Oct; 280(43):35822-8. PubMed ID: 16109721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PIAS proteins as regulators of small ubiquitin-related modifier (SUMO) modifications and transcription.
    Palvimo JJ
    Biochem Soc Trans; 2007 Dec; 35(Pt 6):1405-8. PubMed ID: 18031232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PIASxα ligase enhances SUMO1 modification of PTEN protein as a SUMO E3 ligase.
    Wang W; Chen Y; Wang S; Hu N; Cao Z; Wang W; Tong T; Zhang X
    J Biol Chem; 2014 Feb; 289(6):3217-30. PubMed ID: 24344134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sumoylation of Smad4, the common Smad mediator of transforming growth factor-beta family signaling.
    Lee PS; Chang C; Liu D; Derynck R
    J Biol Chem; 2003 Jul; 278(30):27853-63. PubMed ID: 12740389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein inhibitor of activated STAT Y (PIASy) and a splice variant lacking exon 6 enhance sumoylation but are not essential for embryogenesis and adult life.
    Wong KA; Kim R; Christofk H; Gao J; Lawson G; Wu H
    Mol Cell Biol; 2004 Jun; 24(12):5577-86. PubMed ID: 15169916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The DEAD-box protein DP103 (Ddx20 or Gemin-3) represses orphan nuclear receptor activity via SUMO modification.
    Lee MB; Lebedeva LA; Suzawa M; Wadekar SA; Desclozeaux M; Ingraham HA
    Mol Cell Biol; 2005 Mar; 25(5):1879-90. PubMed ID: 15713642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamin interacts with members of the sumoylation machinery.
    Mishra RK; Jatiani SS; Kumar A; Simhadri VR; Hosur RV; Mittal R
    J Biol Chem; 2004 Jul; 279(30):31445-54. PubMed ID: 15123615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.